Veracyte Inc (NASDAQ:VCYT)

5.70
Delayed Data
As of Feb 16
 +0.09 / +1.60%
Today’s Change
5.23
Today|||52-Week Range
9.80
-12.71%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close5.61
Today’s open5.57
Day’s range5.52 - 5.70
Volume118,191
Average volume (3 months)160,658
Market cap$194.0M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+16.15%
Earnings growth (this year)+20.55%
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratioNM
Price/Sales3.43
Price/Book3.23

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...+0.04+1.73%
OXFDOxford Immunotec Glo...+0.05+0.42%
QTNTQuotient Ltd+0.20+4.75%
TRIBTrinity Biotech PLC-0.03-0.45%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 21, 2018
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$65.1M
Annual profit (last year)-$31.4M
Net profit margin-48.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Bonnie H. Anderson
President &
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts